Global Herceptin (Trastuzumab) Biosimilars Pipeline Guide 2021
October 22, 2021 04:53 ET
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...
Global Drug-Eluting Bioabsorbable Stents Market Is Expected to Reach USD 579.87 Million by 2027 : Fior Markets
September 29, 2020 19:00 ET
|
Fior Markets
Newark, NJ, Sept. 29, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global drug-eluting bioabsorbable stents market is expected to grow from USD 393.31 million in 2019...
Updated Results from Phase I Study of CB-839 in Combination with Paclitaxel in Patients with Triple Negative Breast Cancer to be Presented at the 2017 San Antonio Breast Cancer Symposium
December 05, 2017 08:00 ET
|
Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on discovering and developing novel small...